|
Big Ten CRC News & Events
|
|
Big Ten researchers, collaborators convene for 2019 Summit
Investigators from Big Ten Cancer Research Consortium (Big Ten CRC) member institutions gathered at Big Ten Conference Headquarters in Chicago for the consortium's annual summit, September 21. The 2019 Summit, hosted by the University of Iowa Holden Comprehensive Cancer Center, featured topics presented by Big Ten investigators and industry representatives, and opportunities to discuss current and potential collaborations.
|
|
Fellows, faculty share lessons in clinical trial design at Vail Workshop
Every year selected junior investigators learn how to design effective clinical trials for therapeutic interventions in treating cancer during an intensive week-long workshop hosted jointly by the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). The conference, known in oncology circles as the "Vail Workshop," is held in Vail, Colo. and is an ideal backdrop for clinical and research oncologists to unplug, network, and gain valuable feedback from leading investigators in oncology in a retreat-like setting.
During the 2019 Vail Workshop, held July 27 - Aug. 2, several members of Big Ten universities and cancer centers participated as faculty and selected fellows.
|
|
Ohio State appoints Shields as Steering Committee member
The Ohio State University has appointed
Peter Shields, MD, to serve as the university's representative on the Big Ten CRC Steering Committee. Dr. Shields, a thoracic medical oncologist and deputy director of
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James), oversees the scientific research programs and research infrastructure of the OSUCCC-James, which includes more than 340 cancer researchers and their teams from 11 of Ohio State's 15 colleges. His research focus and interests are in how cancer forms and how to prevent it, with an emphasis on developing tests to identify people who are at greatest risk of cancer.
|
|
Furqan represents University of Iowa on Steering Committee
The University of Iowa recently selected
Muhammad Furqan, MD, to serve on the Big Ten CRC Steering Committee. Dr. Furqan is a medical oncologist and clinical associate professor of internal medicine - Hematology, Oncology and Blood and Marrow Transplantation at the University of Iowa Carver College of Medicine. Dr. Furqan specializes in lung cancer and leads the thoracic multidisciplinary oncology group at the University of Iowa Holden Comprehensive Cancer Center. Dr. Furqan also supervises clinical services at the Holden Comprehensive Cancer Center as medical director.
|
|
Northwestern University
Member Feature
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University, one of only 51 NCI-designated Comprehensive Cancer Centers in the nation, is dedicated to scientific discovery, advancing medical knowledge, providing compassionate, state-of-the-art cancer care, and training the next generation of clinicians and scientists. Outstanding basic, translational, and clinical research complements a full range of prevention, early detection, treatment, rehabilitation, and palliative care programs for all types of cancer.
Read more.
|
|
Michigan State University
Member Feature
The Michigan State University (MSU) Breslin Cancer Center provides care to thousands of patients each year. Interdisciplinary cancer clinics create a treatment plan that involves the patient, oncologists, radiation oncologists, surgeons, and other experts. The Division of Hematology/Oncology in the MSU College of Human Medicine has an active clinical trials program.
Read more.
|
|
Integrative oncology training program accepting applications
Applications are now open for a nationwide integrative oncology training program. The Integrative Oncology Scholars Program at the University of Michigan is funded by a National Cancer Institute R25 grant. Eligible participants, include a multidisciplinary selection of physicians, physician assistants, nurses, psychologists, social workers, physical or occupational therapists, and pharmacists, who are actively engaged in clinical oncology practice.
|
|
